HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Woo Hyun Park Selected Research

benzyloxycarbonylleucyl-leucyl-leucine aldehyde

4/2012MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
12/2011Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
6/2011Proteasome inhibition by MG132 induces growth inhibition and death of human pulmonary fibroblast cells in a caspase-independent manner.
7/2010MG132 as a proteasome inhibitor induces cell growth inhibition and cell death in A549 lung cancer cells via influencing reactive oxygen species and GSH level.
6/2010MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion.
6/2010Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
4/2010The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
1/2010The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
7/2009The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Woo Hyun Park Research Topics

Disease

32Lung Neoplasms (Lung Cancer)
05/2015 - 08/2008
25Neoplasms (Cancer)
01/2016 - 02/2003
7Adenocarcinoma
12/2011 - 04/2008
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2004 - 02/2003
4Lymphoma (Lymphomas)
07/2003 - 11/2002
2Necrosis
02/2015 - 05/2010
2Hypertension (High Blood Pressure)
06/2011 - 09/2008
2Cardiomegaly (Heart Hypertrophy)
12/2010 - 09/2008
2Renal Cell Carcinoma (Grawitz Tumor)
05/2003 - 04/2003
1Inflammation
01/2016
1Mesothelioma
01/2016
1Ischemia
08/2012
1Reperfusion Injury
08/2012
1Fibrosis (Cirrhosis)
07/2012
1Esophageal Neoplasms (Esophageal Cancer)
12/2011
1Heart Failure
06/2011
1Cardiovascular Diseases (Cardiovascular Disease)
06/2011
1Right Ventricular Hypertrophy
12/2010
1Anoxia (Hypoxia)
12/2010
1Renal Hypertension
09/2009
1Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2009
1Hypertrophy
12/2008
1Stomach Neoplasms (Stomach Cancer)
08/2008
1Leukemia
03/2004
1Colonic Neoplasms (Colon Cancer)
02/2003
1Multiple Myeloma
03/2002

Drug/Important Bio-Agent (IBA)

29Glutathione (Reduced Glutathione)IBA
01/2016 - 11/2008
28Reactive Oxygen Species (Oxygen Radicals)IBA
05/2015 - 11/2008
9benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2012 - 07/2009
8Proteasome Endopeptidase Complex (Proteasome)IBA
04/2012 - 01/2010
7Gallic AcidIBA
07/2013 - 05/2010
6PyrogallolIBA
01/2010 - 08/2008
5Cysteine (L-Cysteine)FDA Link
01/2016 - 04/2010
4arsenic trioxide (Trisenox)FDA Link
08/2012 - 08/2008
4Atrial Natriuretic Factor (ANF)IBA
12/2010 - 09/2008
4Antimycin AIBA
01/2010 - 09/2008
4Monensin (Coban)IBA
07/2003 - 11/2002
3pyrimidin-2-one beta-ribofuranosideIBA
11/2014 - 10/2012
3Buthionine SulfoximineIBA
08/2010 - 08/2008
2Auranofin (Ridaura)FDA Link
01/2016 - 02/2015
2ThioredoxinsIBA
05/2015 - 03/2015
2A-Form DNA (A-DNA)IBA
11/2014 - 04/2013
2Propyl GallateIBA
08/2013 - 03/2011
2Phosphotransferases (Kinase)IBA
08/2013 - 06/2010
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2013 - 08/2012
2urotensin IIIBA
08/2012 - 12/2010
2Protein Kinases (Protein Kinase)IBA
05/2012 - 05/2010
1Thioredoxin-Disulfide ReductaseIBA
01/2016
1OxygenIBA
01/2016
1AsbestosIBA
01/2016
1EnzymesIBA
05/2015
1Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
12/2013
1AntioxidantsIBA
08/2013
1trichostatin A (A 300)IBA
01/2013
1Krebs-Henseleit solutionIBA
08/2012
1parthenolideIBA
07/2012
1Thioacetamide (Thioacetamid)IBA
07/2012
1Aligeron (AS 2)IBA
04/2012
1Paclitaxel (Taxol)FDA LinkGeneric
12/2011
1leucylleucine (Leu-Leu)IBA
12/2011
1leucinalIBA
12/2011
1Butylated Hydroxyanisole (BHA)IBA
03/2011
1MonocrotalineIBA
12/2010
1Pen(5)-Trp(7)-Orn(8)- urotensin II (4-11)IBA
12/2010
1Type C PhospholipasesIBA
12/2010
1Inositol (Myoinositol)IBA
12/2010
1Protein Kinase CIBA
12/2010
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2010
1PD 98059IBA
05/2010
1Ditiocarb (Sodium Diethyldithiocarbamate)FDA Link
04/2010
1phenylhydrazoneIBA
11/2009
1Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone (FCCP)IBA
11/2009
1mesoxalonitrileIBA
11/2009
1DinoprostIBA
09/2009
11,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA
01/2009
1AdenosineFDA LinkGeneric
12/2008
14,4'- Diisothiocyanostilbene- 2,2'- Disulfonic Acid (DIDS)IBA
09/2008
1Proteins (Proteins, Gene)IBA
09/2008
12,4-Dinitrophenol (2,4 Dinitrophenol)IBA
04/2008
1Liposomes (Liposome)IBA
03/2004
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2004
1RNA (Ribonucleic Acid)IBA
03/2004
1AntigensIBA
03/2004
1Histone Deacetylase InhibitorsIBA
05/2003
1Transforming Growth Factor beta1 (TGF beta 1)IBA
03/2002
1hydroxide ionIBA
03/2002
1seocalcitolIBA
03/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
12/2011